GlassScriptPhysician profile
Leslie S Ledbetter
NPI 1477518538
$13,063.91
in general payments reported to CMS, 2019-2025
32 companies · $3,111 in 2025
The $3,111 reported for 2025 was more than what 85% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,029 · 2020: $397 · 2021: $239 · 2022: $1,477 · 2023: $2,514 · 2024: $3,297 · 2025: $3,111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,736 · Education: $186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,736.37 |
| Education | $186.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,014.54 | 2019-2025 | |
| Janssen Biotech, INC. | $1,909.37 | 2019-2025 | Tremfya, Stelara, Simponi |
| Regeneron Healthcare Solutions, INC. | $1,036.32 | 2019-2025 | Dupixent |
| Novartis Pharmaceuticals Corporation | $915.50 | 2019-2025 | |
| Lilly USA, LLC | $872.88 | 2019-2025 | Taltz, Olumiant, Ebglyss |
| Incyte Corporation | $830.01 | 2022-2025 | Opzelura |
| Genzyme Corporation | $734.46 | 2019-2025 | |
| Arcutis Biotherapeutics, INC. | $555.06 | 2023-2025 | Zoryve |
| Sun Pharmaceutical Industries INC. | $524.20 | 2019-2025 | Absorica Ld, Winlevi, Ilumya |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $436.47 | 2019-2025 | Jublia, Cabtreo, Arazlo |
| Amgen INC. | $417.60 | 2019-2025 | Otezla, Otezla |
| Allergan, INC. | $414.40 | 2019-2022 | |
| Pfizer INC. | $392.99 | 2019-2025 | |
| Ucb, INC. | $366.78 | 2019-2025 | Bimzelx, Cimzia |
| Galderma Laboratories, L.P. | $348.26 | 2019-2025 | Nemluvio, Aklief, Oracea |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Revance Therapeutics, INC. | $293.30 | 2024-2025 | Daxxify |
| E.R. Squibb & Sons, L.L.C. | $258.32 | 2022-2025 | Sotyktu |
| Almirall LLC | $183.64 | 2019-2023 | Klisyri |
| Celgene Corporation | $170.39 | 2019 | |
| Leo Pharma INC. | $103.82 | 2019-2025 | Adbry, Anzupgo |
| Fresenius Kabi USA, LLC | $57.17 | 2023-2024 | Idacio |
| Dermira, INC. | $43.65 | 2019 | |
| Epi Health, LLC | $40.01 | 2019 | |
| Krystal Biotech INC | $21.36 | 2025 | Vyjuvek |
| Dusa Pharmaceuticals, INC. | $20.11 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.60 | 2023 | Cyltezo |
| Aclaris Therapeutics, INC. | $18.10 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $15.02 | 2024 | Simlandi |
| Verrica Pharmaceuticals INC. | $14.38 | 2025 | Ycanth |
| Botanix Sb INC | $14.29 | 2025 | Sofdra |
| Vyne Pharmaceuticals INC. | $13.89 | 2020 | |
| Biofrontera INC. | $9.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leslie Ledbetter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.